Neuropsychiatric impairment in Parkinson's Disease

8,105
Total downloads
39k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 12 Jun 2017

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder

Per Svenningsson
Sven Pålhagen
Aleksander A. Mathé

doi 10.3389/fpsyt.2017.00102

3,364 views
21 citations

ORIGINAL RESEARCH

Published on 12 Jun 2017

Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson’s Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task

Mohammad M. Herzallah
Hussain Y. Khdour
Ahmad B. Taha
Amjad M. Elmashala
Hamza N. Mousa
Mohamad B. Taha
Zaid Ghanim
Mahmud M. Sehwail
Adel J. Misk
3 more
Mark A. Gluck

doi 10.3389/fpsyt.2017.00084

4,853 views
16 citations

ORIGINAL RESEARCH

Published on 24 Apr 2017

Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis

Sara Garofalo
Azucena Justicia
Gonzalo Arrondo
Anna O. Ermakova
Pranathi Ramachandra
Carina Tudor-Sfetea
Trevor W. Robbins
Roger A. Barker
Paul C. Fletcher
Graham K. Murray

doi 10.3389/fneur.2017.00156

2,711 views
11 citations

OPINION

Published on 23 Jun 2016

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications

Angie A. Kehagia

doi 10.3389/fpsyt.2016.00110

4,988 views
15 citations

ORIGINAL RESEARCH

Published on 23 Jun 2016

Apathy, Novelty Processing, and the P3 Potential in Parkinson’s Disease

David A. S. Kaufman
Dawn Bowers
Michael S. Okun
Ryan Van Patten
William M. Perlstein

doi 10.3389/fneur.2016.00095

4,092 views
14 citations

HYPOTHESIS AND THEORY

Published on 30 May 2016

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?

Jean-Luc Houeto
Robin Magnard
Jeffrey W. Dalley
David Belin
Sebastien Carnicella

doi 10.3389/fpsyt.2016.00091

6,684 views
34 citations

REVIEW

Published on 20 May 2016

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease

Lucy M. Collins
Caroline H. Williams-Gray

doi 10.3389/fpsyt.2016.00089

8,606 views
48 citations

ORIGINAL RESEARCH

Published on 21 Dec 2015

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients

Ruth A. Wood
Sarah A. Hopkins
Kuven K. Moodley
Dennis Chan

doi 10.3389/fneur.2015.00263

9,321 views
35 citations

Share on

Frontiers in Psychiatry

NeurodegenerationOffline

Participating Journals

Frontiers in Neurology
- NeurodegenerationOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- Neurodegeneration
- 3.2 impact factor
- 6.2 citescore

Impact

39kTopic views
29kArticle views
8,105Article downloads

View impact

Submit your idea

Articles

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder

Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson’s Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task

Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications

Apathy, Novelty Processing, and the P3 Potential in Parkinson’s Disease

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson’s Disease Patients

Frontiers in Psychiatry

Participating Journals

Impact